tyb
SAM613 Clipper C-40B approaching Irish Coast from JBA
Hungarian AF HUAF564 Falcon 7X from Kecksemet AB
Top Insider sales/buys-week ending April 10th, 2020
Sales
Institutional
Crowdstrike Holdings, Inc sold by Warburg Pincus Private Equity: $575.10m- Apr 6
https://www.finviz.com/insidertrading.ashx?oc=1414565&tc=7&b=2
Individual
LuLu Lemon sold by Former CEO/Founder: $49.99m-Apr 6
https://www.finviz.com/insidertrading.ashx?oc=1407029&tc=7&b=2
Buys
Institutional
Mersana Therapeutics bough by Bain Capital Life Sciences LP: $20.64m-Apr 7
Founder of Reify Corp., Andrew A. F. Hack presently is Managing Director at Bain Capital Life Sciences LP. He is also on the board of Mersana Therapeutics, Inc. and Allena Pharmaceuticals, Inc. In his past career he occupied the position of Chief Financial & Accounting Officer of Editas Medicine, Inc., Analyst at HealthCor Management LP, Portfolio Manager at Millennium Management LLC, Analyst at Carlyle-Blue Wave Partners and Analyst at MPM BioEquities Adviser LLC. Dr. Hack received an undergraduate degree, a graduate degree and a doctorate from The University of Chicago. Mersana Therapeutics, Inc. is a biotechnology company. The Company is focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies.
https://www.marketscreener.com/MERSANA-THERAPEUTICS-INC-35939999/company/
https://www.finviz.com/insidertrading.ashx?oc=1657434&tc=7&b=2
Buy
Individual
Nexpoint Residential Trust bought by President: $ 2.06m-Apr 3
NexPoint Residential Trust, Inc. is an externally managed real estate investment trust (REIT). The Company's investment objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions and achieve long-term capital appreciation for its stockholders through targeted management and a value-add program. The Company is focused on multifamily investments primarily located in the Southeastern and Southwestern United States. All of the Company's business operations are conducted through NexPoint Residential Trust Operating Partnership, L.P. (OP). The sole limited partner of the OP is the Company. Its subsidiary, NexPoint Residential Trust Operating Partnership GP, LLC, is the sole general partner of the OP. As of December 31, 2016, the Company owned 39 properties representing 12,965 units in eight states, including two Parked Assets. The Company's advisor is NexPoint Real Estate Advisors, L.P. Number of employees : 3 people.
https://www.marketscreener.com/NEXPOINT-RESIDENTIAL-TRUS-21269406/company/
https://www.finviz.com/insidertrading.ashx?oc=1228922&tc=1&b=2
RAF RRR2763 Airbus KC-2 Voyager out of Nairobi, Kenya nw